Who we are
Our Mission is to bring personalised medicine to every IFV patient. We see ourselves as an innovative research-based laboratory that contributes to patients’ well-being in partnership with IVF clinics worldwide. All team members value continuous research for improving the existing personalised medicine tests and finding better solutions.
Send an Email
Celvia CC AS
Call us
Kaarel Krjutškov, PhD
Kadi Sagor
Susanna Janno
Neeme Tõnisson M.D., PhD
Andres Salumets, PhD
Priit Palta, PhD
Külli Samuel
Signe Mölder, MSc
The beREADY team
Our team consists of eminent researchers in their field – five members with a PhD and a doctor of medicine (MD). We collaborate with several leading universities in personalised and precision medicine, molecular biology, genetics and genomics. For example Karolinska Institutet, University of Helsinki, Leuven University, Oulu University, Granada University and others. In total, the we have published over 300 scientific articles and have applied for multiple international patents. We have successfully established IVF clinics and have been nominated for “Innovation of the Year” in Swedish business awards in 2016.
CELVIA is focused on performing research and providing service. Our team develops and promotes genetic testing assays in the field of assisted reproductive biology as well as in all obstetrical and gynecological clinics. The laboratory also provides other advanced genetic testing services such as non-invasive prenatal genetic testing NIPT (www.niptify.ee) and preimplantation genetic screening (PGT-A). The NIPTIFY is reimbursed by Estonia social security fund since January 2020. That is why NIPTIFY test is a market leader NIPT in Estonia. CCHT is an approved service provider by an Estonian Health Board with a license number L05235.
Laboratory quality and approvals
